18F ML-10 for Early Detection of Response of Brain Metastases to WBRT

NCT00791063 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aposense Ltd.